5-45695966-G-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_021072.4(HCN1):​c.128C>A​(p.Pro43Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000604 in 1,324,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P43S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000051 ( 0 hom. )

Consequence

HCN1
NM_021072.4 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.32

Publications

1 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20324373).
BS2
High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN1NM_021072.4 linkc.128C>A p.Pro43Gln missense_variant Exon 1 of 8 ENST00000303230.6 NP_066550.2 O60741Q86WJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN1ENST00000303230.6 linkc.128C>A p.Pro43Gln missense_variant Exon 1 of 8 1 NM_021072.4 ENSP00000307342.4 O60741
HCN1ENST00000673735.1 linkc.128C>A p.Pro43Gln missense_variant Exon 1 of 9 ENSP00000501107.1 A0A669KB45
HCN1ENST00000634658.1 linkc.128C>A p.Pro43Gln missense_variant Exon 1 of 2 3 ENSP00000489134.1 A0A0U1RQR7
HCN1ENST00000638054.1 linkn.-241C>A upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000134
AC:
2
AN:
149496
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000149
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000511
AC:
6
AN:
1175170
Hom.:
0
Cov.:
32
AF XY:
0.00000523
AC XY:
3
AN XY:
573228
show subpopulations
African (AFR)
AF:
0.0000875
AC:
2
AN:
22862
American (AMR)
AF:
0.00
AC:
0
AN:
10174
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16236
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25306
South Asian (SAS)
AF:
0.0000224
AC:
1
AN:
44706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
27390
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3272
European-Non Finnish (NFE)
AF:
0.00000204
AC:
2
AN:
977996
Other (OTH)
AF:
0.0000212
AC:
1
AN:
47228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149612
Hom.:
0
Cov.:
32
AF XY:
0.0000137
AC XY:
1
AN XY:
73020
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000243
AC:
1
AN:
41096
American (AMR)
AF:
0.00
AC:
0
AN:
15052
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4916
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4760
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9814
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.0000149
AC:
1
AN:
67242
Other (OTH)
AF:
0.00
AC:
0
AN:
2080
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000203476), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy Uncertain:1
Oct 28, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 43 of the HCN1 protein (p.Pro43Gln). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with HCN1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HCN1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Uncertain
0.060
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.13
T;T
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.50
T;T
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.20
T;T
MetaSVM
Uncertain
-0.21
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
2.3
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.86
N;.
REVEL
Uncertain
0.32
Sift
Benign
0.031
D;.
Sift4G
Uncertain
0.059
T;T
Polyphen
0.089
B;.
Vest4
0.14
MutPred
0.14
Loss of methylation at R38 (P = 0.0837);Loss of methylation at R38 (P = 0.0837);
MVP
0.67
MPC
2.5
ClinPred
0.60
D
GERP RS
3.0
PromoterAI
-0.012
Neutral
Varity_R
0.12
gMVP
0.17
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060500095; hg19: chr5-45696068; API